Secretion of mouse growth hormone by transduced primary human keratinocytes: Prospects for an animal model of cutaneous gene therapy

Journal of Gene Medicine

Volumn 10, Issue 7, 2008, Pages 734-743

  Peroni, Cibele Nunes ^a   Cecchi, Cláudia Regina ^a   Rosauro, Cristiane Wanderley ^a   Nonogaki, Suely ^b   Boccardo, Enrique ^c   Bartolini, Paolo ^a  

^a INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Gene therapy; Immunodeficient dwarf mice; Mouse growth hormone; Organotypic raft cultures; Primary human keratinocytes; Retroviral vector

Indexed keywords

GROWTH HORMONE; RETROVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL BASED GENE THERAPY; CONTROLLED STUDY; EX VIVO GENE TRANSFER; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOLECULAR MIMICRY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; WEIGHT GAIN;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GROWTH HORMONE; HUMANS; KERATINOCYTES; MICE; MODELS, ANIMAL; RETROVIRIDAE;

ANIMALIA; MUS;

EID: 48949120138     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1196     Document Type: Article

References (53)

1. Mavilio F, Pellegrini G, Ferrari S, et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006; 12: 1397-1402.
2. Kikuchi Y, Tamai K, Kaneda Y. Cutaneous gene therapy. J Dermatol Sci 2007; DOI: 10.1016/j.jdermsci.2007.07.006.
3. De Luca M, Pellegrini G. The importance of epidermal stern cells in keratinocyte-mediated gene therapy. Gene Ther 1997; 4: 381-383.
4. Taichman LB. Systemic replacement therapy from genetically modified epidermal keratinocytes. Proc Assoc Am Physicians 1999; 111: 206-210.
5. Jensen TG. Gene transfer into human epidermis as an experimental model for somatic gene transfer. Dan Med Bull 2004; 51: 155-166.
6. Jensen TG. Strategies for long-term gene expression in the skin to treat metabolic disorders. Expert Opin Biol Ther 2004; 4: 677-682.
7. Hengge UR, Bardenheuer W. Gene therapy and the skin. Amer J Med Genet Part C (Sernin Med Genet) 2004; 131C: 93-100.
8. Rheinwald JG, Green H. Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 1975; 6: 317-330.
9. De Luca M, Albanese M, Bondanza S, et al. Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns 1989; 15: 303-309.
10. Morgan RA, Anderson WF. Human gene therapy. Annu Rev Biochem 1993; 62: 191-217.
11. Heartlein MW, Roman VA, Jiang J, et al. Long-term production and delivery of human growth hormone in vivo. Proc Natl Acad Sci USA 1994; 91: 10967-10971.
12. He X, Goldsmith CM, Marmary Y, et al. Systemic action of growth human hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther 1998; 5: 537-541.
13. Krueger GG, Jorgensen CM, Matsunami N, et al. Persistent transgene expression and normal differentiation of immortalized human keratinocytes in vivo. J Invest Dermatol 1999; 112: 233-239.
14. Miller AD, Miller DG, Garcia JV, et al. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993; 217: 581-599.
15. Robbins PD, Tahara H, Ghivizzani SC. Viral vectors for gene therapy. Trends Biotechnol 1998; 16: 35-40.
16. Choate KA, Khavari PA. Sustainability of keratinocyte gene transfer and cell survival in vivo. Hum Gene Ther 1997; 8: 895-901.
17. Hengge UR. Gene therapy progress and prospects: the skin - easily accessible, but still far away. Gene Ther 2006; 13: 1555-1563.
18. Morgan JR, Barrandon Y, Green H, et al. Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 1987; 237: 1476-1479.
19. Teumer J, Lindahl A, Green H. Human growth hormone in the blood of athymic mice grafted with cultures of hormone-secreting human keratinocytes. FASEB J 1990; 4: 3245-3250.
20. Jensen UB, Jensen TG, Jensen PKA, et al. Gene transfer into cultured human epidermis and its transplantation onto immunodeficient mice: an experimental model for somatic gene therapy. J Invest Dermatol 1994; 103: 391-394.
21. Wang X, Zinkel S, Polonsky K, et al. Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy. Proc Natl Acad Sci USA 1997; 94: 219-226.
22. Peroni CN, Gout PW, Bartolini P. Animal models for growth hormone gene therapy. Curr Gene Ther 2005; 5: 493-509.
23. Bellini MH, Peroni CN, Bartolini P. Increases in weight of growth hormone-deficient and immunodeficient (lit/scid) dwarf mice after grafting of hGH-secreting, primary human keratinocytes. FASEB J 2003; 17: 2322-2324.
24. Al-Hendy A, Hortelano G, Tannenbaum GS, et al. Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - an alternate approach to somatic gene therapy. Hum Gene Ther 2005; 6: 165-175.
25. Marmary Y, Parlow AF, Goldsmith CM, et al. Construction and in vivo efficacy of a replication-deficient recombinant adenovirus encoding murine growth hormone. Endocrinology 1999; 140: 260-265.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
27. Burnette WN. 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112: 195-203.
28. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991-1995.
29. Dalmora S, Oliveira JE, Affonso R, et al. Analysis of recombinant human growth hormone directly in osmotic shock fluids. J Chromatogr A 1997; 782: 199-210.
30. Barrandon Y, Li V, Green H. New techniques for the grafting of cultured human epidermal cells onto athymic animals. J Invest Dermatol 1988; 91: 315-318.
31. Kolodka TM, Garlick JA, Taichman LB. Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci USA 1998; 95: 4356-4361.
32. Bellini MH, Bartolini P. In vivo bioassay for the potency determination of human growth hormone in dwarf 'little' mice. Endocrinology 1993; 132: 2051-2055.
33. Bellini MH, Mathor MB, De Luca M, et al. Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes. J Endocrinol Invest 1998; 21: 1-6.
34. Deitel K, Dantzer D, Ferguson P, et al. Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation. J Surg Oncol 2002; 81: 75-79.
35. Williams DA, Leminschka IR, Nathan DG, et al. Introduction of new genetic material into pluripotent hematopoietic stem-cells of the mouse. Nature 1984; 310: 476-480.
36. Mathor MB, Ferrari G, Dellambra E, et al. Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci USA 1996; 93: 10371-10376.
37. Meyer CWE, Korthaus D, Jagla W, et al. A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity. Endocrinology 2004; 145: 2531-2541.
38. Oliveira JE, Mendonça F, Peroni CN, et al. Determination of Chinese hamster ovary cell-derived recombinant thyrotropin by reversed-phase liquid chromatography. J Chromatogr B 2003; 787: 345-355.
39. Garlick JA, Taichman LB. Effect of TGF-β1 on re-epithelization of human keratinocytes in vitro: an organotypic model. J Invest Dermatol 1994; 103: 554-559.
40. Peroni CN, Cecchi CR, Damiam R, et al. High-level secretion of growth hormone by retrovirally transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy. Mol Biotechnol 2006; 34: 239-245.
41. Gerrard AJ, Hudson DL, Brownlee GG, et al. Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 1993; 3: 180-183.
42. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932.
43. Fenjves ES, Smith J, Zaradic S, et al. Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. Hum Gene Ther 1994; 5: 1241-1248.
44. Ghazizadeh S, Kalish RS, Taichman LB. Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy. Mol Ther 2003; 7: 296-303.
45. Li YC, Guan CT, Zhao KQ, et al. Pharmacokinetics of lactosaminated recombinant human growth hormone in mice. Acta Pharmacol Sin 2001; 22: 450-454.
46. Klerman EB, Adler GK, Jin MS, et al. A statistical model of diurnal variation in human growth hormone. Am J Physiol Endocrinol Metab 2003; 285: 1118-1126.
47. Melmed S, Kleinberg DL. Anterior pituitary. In Williams Textbook of Endocrinology, Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds). WB Saunders Co: Philadelphia, 2003; 177-279.
48. Bidlingmaier M, Wu Z, Strasburger CJ. Problems with GH doping in sports. J Endocrinol Invest 2004; 26: 924-931.
49. Stockschlader MAR, Schuening FG, Graham TC, et al. Transplantation of retrovirus-transduced canine keratinocytes expressing the β-galactosidase gene. Gene Ther 1994; 1: 317-322.
50. Ghazizadeh S, Harrington R, Taichman LB. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy. Gene Ther 1999; 6: 1267-1275.
51. Ghazizadeh S, Taichman LB. Virus-mediated gene transfer for cutaneous gene therapy. Hum Gene Ther 2000; 11: 2247-2251.
52. Prud'homme GJ, Draglia-Akli R, Wang Q. Plasmid-based gene therapy of diabetes mellitus. Gene Ther 2007; 14: 553-564.
53. Flowers MED, Stockschlaeder MAR, Schuening FG, et al. Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 1990; 87: 2349-2353.